Beate Pfistner

7.4k total citations · 2 hit papers
43 papers, 5.1k citations indexed

About

Beate Pfistner is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Beate Pfistner has authored 43 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pathology and Forensic Medicine, 26 papers in Pulmonary and Respiratory Medicine and 10 papers in Genetics. Recurrent topics in Beate Pfistner's work include Lymphoma Diagnosis and Treatment (35 papers), Lung Cancer Treatments and Mutations (26 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Beate Pfistner is often cited by papers focused on Lymphoma Diagnosis and Treatment (35 papers), Lung Cancer Treatments and Mutations (26 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Beate Pfistner collaborates with scholars based in Germany, United States and Czechia. Beate Pfistner's co-authors include Volker Diehl, Malik E. Juweid, Randy D. Gascoyne, Lena Specht, Richard I. Fisher, Bertrand Coiffier, Richard T. Hoppe, Bruce D. Cheson, Steven T. Rosen and Sandra J. Horning and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Beate Pfistner

40 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Revised Response Criteria for Malignant Lymphoma

2007 3.2k citations Bruce D. Cheson, Beate Pfistner et al. Journal of Clinical Oncology profile →
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

2002 755 citations Beate Pfistner, Markus Sieber et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beate Pfistner Germany	16	4.3k	2.5k	1.6k	1.1k	965	43	5.1k
Stefano Luminari Italy	35	4.3k 1.0×	2.6k 1.0×	1.3k 0.8×	1.2k 1.1×	1.1k 1.1×	216	5.6k
Christophe Fermé France	26	3.7k 0.9×	2.4k 1.0×	1.3k 0.8×	1.2k 1.1×	617 0.6×	98	4.3k
Francesco Merli Italy	33	3.4k 0.8×	1.8k 0.7×	1.2k 0.7×	871 0.8×	1.0k 1.0×	157	4.3k
B Coiffier France	18	3.7k 0.9×	2.4k 0.9×	1.0k 0.6×	1.4k 1.3×	564 0.6×	43	4.4k
Carol S. Portlock United States	38	4.2k 1.0×	2.7k 1.1×	1.4k 0.8×	1.5k 1.4×	966 1.0×	119	5.6k
P Lederlin France	22	5.1k 1.2×	3.3k 1.3×	1.9k 1.2×	2.0k 1.9×	714 0.7×	76	6.5k
José Thomas Belgium	38	3.3k 0.8×	1.5k 0.6×	1.2k 0.8×	1.1k 1.0×	1.2k 1.3×	77	4.3k
Jehan Dupuis France	32	3.1k 0.7×	1.8k 0.7×	729 0.4×	926 0.9×	617 0.6×	115	4.1k
Luigi Rigacci Italy	28	3.1k 0.7×	1.6k 0.6×	974 0.6×	809 0.8×	798 0.8×	144	4.0k
Paul A. Hamlin United States	33	2.9k 0.7×	2.0k 0.8×	914 0.6×	925 0.9×	521 0.5×	155	4.0k

Countries citing papers authored by Beate Pfistner

Since Specialization

Citations

This map shows the geographic impact of Beate Pfistner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beate Pfistner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beate Pfistner more than expected).

Fields of papers citing papers by Beate Pfistner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beate Pfistner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beate Pfistner. The network helps show where Beate Pfistner may publish in the future.

Co-authorship network of co-authors of Beate Pfistner

This figure shows the co-authorship network connecting the top 25 collaborators of Beate Pfistner. A scholar is included among the top collaborators of Beate Pfistner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beate Pfistner. Beate Pfistner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paulus, Ursula, Sandra De Meyer, Beate Pfistner, et al.. (2008). Systematic review about data quality and protocol compliance in clinical trials. SHILAP Revista de lepidopterología. 2 indexed citations

Eich, Hans Theodor, Axel Goßmann, Andreas Engert, et al.. (2007). A Contribution to Solve the Problem of the Need for Consolidative Radiotherapy after Intensive Chemotherapy in Advanced Stages of Hodgkin's Lymphoma—Analysis of a Quality Control Program Initiated by the Radiotherapy Reference Center of the German Hodgkin Study Group (GHSG). International Journal of Radiation Oncology*Biology*Physics. 69(4). 1187–1192. 17 indexed citations

Sieniawski, Michal, Thorsten Reineke, Lucia Nogová, et al.. (2007). Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG). Blood. 111(1). 71–76. 82 indexed citations

Cheson, Bruce D., Beate Pfistner, Malik E. Juweid, et al.. (2006). Recommendations for revised response criteria for malignant lymphoma. Journal of Clinical Oncology. 24(18_suppl). 7507–7507. 6 indexed citations

Bohlius, Julia, Heinz Haverkamp, Volker Diehl, et al.. (2006). Identification of Prognostic Factors in Early Unfavorable Stage Hodgkin’s Lymphoma (HL): An Individual Patient Data Meta-Analysis.. Blood. 108(11). 2473–2473. 1 indexed citations

Klimm, Beate, Heinz Haverkamp, Andreas Lohri, et al.. (2006). Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group. Annals of Oncology. 18(2). 357–363. 42 indexed citations

Pfistner, Beate, et al.. (2005). International harmonization of trial parameters in malignant lymphoma. European Journal Of Haematology. 75(s66). 53–54. 8 indexed citations

Diehl, Volker, Corinne Brillant, Andreas Engert, et al.. (2005). HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin’s lymphoma. Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG). Journal of Clinical Oncology. 23(16_suppl). 6506–6506. 34 indexed citations

Creutzig, Ursula, Martin Zimmermann, Irene Krämer, et al.. (2005). Quality Management for Clinical Trials within the German Competence Network Paediatric Oncology and Haematology. Oncology Research and Treatment. 28(6-7). 333–336. 3 indexed citations

10.

Šmardová, Lenka, et al.. (2005). Successful mobilization of peripheral blood stem cells with the DHAP regimen (dexamethasone, cytarabine, cisplatinum) plus granulocyte colony-stimulating factor in patients with relapsed Hodgkin's disease. Leukemia & lymphoma. 46(7). 1017–1022. 20 indexed citations

11.

Klimm, Beate, Volker Diehl, Beate Pfistner, & Andreas Engert. (2005). Current treatment strategies of the German Hodgkin Study Group (GHSG). European Journal Of Haematology. 75(s66). 125–134. 15 indexed citations

12.

Josting, Andreas, Jeremy Franklin, Michal Sieniawski, et al.. (2005). Outcome of Patients Progressing or Relapsing after Primary Treatment with Two Cycles of Chemotherapy and Radiotherapy for Early Stage (Favorable) Hodgkin’s Disease.. Blood. 106(11). 818–818. 1 indexed citations

13.

Ballová, Veronika, Jens Ulrich Rüffer, Heinz Haverkamp, et al.. (2004). A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly). Annals of Oncology. 16(1). 124–131. 109 indexed citations

14.

Diehl, Volker, Corinne Brillant, Jeremy Franklin, et al.. (2004). Beacopp Chemotherapy for Advanced Hodgkin’s Disease: Results of Further Analyses of the HD9- and HD12- Trials of the German Hodgkin Study Group (GHSG).. Blood. 104(11). 307–307. 26 indexed citations

15.

Diehl, Volker, Corinne Brillant, Andreas Engert, et al.. (2004). Reduction of Combined Modality Treatment Intensity in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the HD 10 Trial of the GHSG.. Blood. 104(11). 1307–1307. 9 indexed citations

16.

Pfistner, Beate, et al.. (2003). Qualitätsstandards und ihre Sicherung für Studienzentralen im Kompetenznetz Maligne Lymphome. Klinische Pädiatrie. 215(6). 341–344. 1 indexed citations

17.

Boudová, L, Emina Torlakovic, Jan Delabie, et al.. (2003). Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood. 102(10). 3753–3758. 116 indexed citations

18.

Engert, Andreas, Petra Schiller, Andreas Josting, et al.. (2003). Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymphoma Study Group. Journal of Clinical Oncology. 21(19). 3601–3608. 294 indexed citations

19.

Josting, Andreas, et al.. (2002). A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2). Annals of Hematology. 81(8). 424–429. 8 indexed citations

20.

Gerber, H, R Fatzer, Edelmira Martí, et al.. (1995). Cerebelläre Abiotrophie bei Vollblutaraber-Fohlen. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact